Tumor cells often upregulate several anti-apoptotic BCL-2 family proteins as a survival mechanism and in CRC, we and others have previously shown that BCL-XL plays a crucial role, particularly also in the stem cell compartment [17,18]. This evidence concerns the gene BCL2L1 and neoplasm.